FES Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP7705a
Background:
FES is the human cellular counterpart of a feline sarcoma retrovirus protein with transforming capabilities. This protein has tyrosine-specific protein kinase activity and that activity is required for maintenance of cellular transformation. Its chromosomal location has linked it to a specific translocation event identified in patients with acute promyelocytic leukemia but it is also involved in normal hematopoiesis.
Other Names:
Tyrosine-protein kinase Fes/Fps, Feline sarcoma/Fujinami avian sarcoma oncogene homolog, Proto-oncogene c-Fes, Proto-oncogene c-Fps, p93c-fes, FES, FPS
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7705a was selected from the N-term region of human FES . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: FES
Gene ID: 2242
Primary Accession: P07332
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
FES is the human cellular counterpart of a feline sarcoma retrovirus protein with transforming capabilities. This protein has tyrosine-specific protein kinase activity and that activity is required for maintenance of cellular transformation. Its chromosomal location has linked it to a specific translocation event identified in patients with acute promyelocytic leukemia but it is also involved in normal hematopoiesis.
Other Names:
Tyrosine-protein kinase Fes/Fps, Feline sarcoma/Fujinami avian sarcoma oncogene homolog, Proto-oncogene c-Fes, Proto-oncogene c-Fps, p93c-fes, FES, FPS
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP7705a was selected from the N-term region of human FES . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: FES
Gene ID: 2242
Primary Accession: P07332
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review